The present invention relates to compounds of formula I which are inhibitors of the BACE1 enzyme. Individual aspects of the present invention are directed to pharmaceutical compositions comprising such compounds and to the use of the compounds for the treatment of disorders wherein reduction of A [beta] deposits is beneficial, such as Alzheimer's disease, (I) .
展开▼